Literature DB >> 3435833

Intracerebral grafting and culture of cryopreserved primate dopamine neurons.

T J Collier1, D E Redmond, C D Sladek, M J Gallagher, R H Roth, J R Sladek.   

Abstract

Dopamine neurons from the ventral midbrain and olfactory bulb of fetal and postnatal African green monkeys were frozen, stored in liquid nitrogen for intervals of 4-28 days, thawed, and tested for viability and growth following intracerebral transplantation into 3 adult monkeys. Well developed tyrosine hydroxylase positive neurons from all donors were seen in intracerebral transplants at 7-50 days after grafting. Freeze-stored neurons also were tested at various intervals by Trypan blue dye exclusion and development in tissue culture. More than 99% of the cryopreserved cells from both pre- and postnatal donors were viable by dye exclusion, and fetal tissue developed neuronal morphology in culture. This evidence further supports the fact that primate neurons survive intracerebral transplantation, even after cryopreservation and storage. The ability to store, transport and verify the transmitter phenotype of neurons offered by this approach is pertinent to possible therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435833     DOI: 10.1016/0006-8993(87)91680-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease.

Authors:  H Sauer; E M Frodl; A Kupsch; G ten Bruggencate; W H Oertel
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Cryopreservation and culture of the human fetal brain tissues.

Authors:  R S Cai; D L Xue; X H Jiang
Journal:  J Tongji Med Univ       Date:  1993

3.  Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls.

Authors:  J R Taylor; J D Elsworth; R H Roth; J R Sladek; T J Collier; D E Redmond
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 4.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 5.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.